Fig 4. Kaplan Meier survival analysis and Cox regression analysis for demonstrating the prognostic and predictive value of the new cfDNA separation platform for patients with gastric cancer.

(a, b) Kaplan Meier survival analysis of different blood tests. 90^th percentile was set as a cutoff for each test. (c, d) Cox regression analysis of different blood test. 90^th percentile was set as a cutoff for each test.